All Updates

Today, the U.S. Senate Committee on Appropriations considered and approved its draft FY26 appropriations bill that includes increases for the National Institutes of Health (NIH) and increases for federal cancer research funding at the National Cancer Institute (NCI).

BIRMINGHAM, Ala. – July 29, 2025 – The American Cancer Society Cancer Action Network (ACS CAN) has placed two new billboards in Alabama to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C. While federal funding is in jeopardy and progress is at stake, ACS CAN is

Today, the U.S. Senate voted to confirm Susan Monarez, PhD, as the next Director of the Centers for Disease Control and Prevention (CDC).

Gov. Gavin Newsom signed Assembly Bill 703 into law, giving California taxpayers the option to voluntarily donate a portion of their state tax return to support childhood cancer research starting January 2026.

Gov. Gavin Newsom signed Assembly Bill 703 into law, giving California taxpayers the option to voluntarily donate a portion of their state tax return to support childhood cancer research starting January 2026.

The American Cancer Society (ACS) and its advocacy affiliate the American Cancer Society Cancer Action Network (ACS CAN) today announced Shane Jacobson as their chief executive officer, effective August 12, 2025. He steps into the role following Dr. Wayne A. I. Frederick who served as interim

The American Cancer Society (ACS) and its advocacy affiliate the American Cancer Society Cancer Action Network (ACS CAN) today announced Shane Jacobson as their chief executive officer, effective August 12, 2025. He steps into the role following Dr. Wayne A. I. Frederick who served as interim

A new report from the nonpartisan Congressional Budget Office (CBO) finds that proposed cuts at the National Institutes of Health (NIH) could lower the number of new drugs that come to market in the next three decades.

A new report from the nonpartisan Congressional Budget Office (CBO) finds that proposed cuts at the National Institutes of Health (NIH) could lower the number of new drugs that come to market in the next three decades.